Yoghurt health drinks are at the centre of safety fears after 24 patients died during clinical trials of probiotics, the dietary supplements containing potentially beneficial bacteria.
Close to one million adolescents in the U.S.—or four percent—are affected by a cluster of cardiac risk factors known as metabolic syndrome that is proven to lead to the early onset of diabetes or heart disease, according to a study published in the Au
A mumps outbreak has been identified among university students in Adelaide. The highly infectious disease has been diagnosed in at least 8 students in the past 2 weeks, with more cases likely.
In much of the world (but not in the U.S.,) drug-coated stents are avoided by cardiologists because of their high cost. To compensate for the inability to use these stents, many cardiologists outside of the U.S. have taken to administering sirolimus (also
Martin Leon, M.D., a leading interventional cardiologist accused of leaking details of a major study weeks before its scheduled release, was barred today from taking part in next year's American College of Cardiology meeting.
ACC/AHA Guidelines for Coronary Angiography: Executive Summary and Recommendations A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) Developed in collaboration
A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention)
An investigational bioabsorbable coronary artery stent, in its first human trials, showed acceptable safety, with efficacy better than bare-metal devices but well short of drug-eluting devices, Dutch researchers said here.
An investigational drug-eluting stent called Xience, coated with everolimus, led to significantly less late lumen loss after nine months than did the Taxus (paclitaxel-eluting) stent, said researchers here today. March 2007
R. Atun, N. Lennox-Chhugani, F. Drobniewski, Y. Samyshkin, und R. Coker. European journal of public health, 14 (3):
267-273(September 2004)M3: Article; Accession Number: 14596725; Atun, R. A. 1; Email Address: r.atun@imperial.ac.uk Lennox-Chhugani, N. 1 Drobniewski, F. 2 Samyshkin, Y. A. 1 Coker, R. J. 3; Affiliation: 1: Centre for Health Management, The Business School, Imperial College London, South Kensington Campus, London, UK 2: Department of Infectious Diseases, Guy's King's and St Thomas' Medical School, East Dulwich Grove, London, UK 3: Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK; Source Info: Sep2004, Vol. 14 Issue 3, p267; Subject Term: COMMUNICABLE diseases; Subject Term: DISEASE management; Subject Term: MEDICINE, Preventive; Subject Term: EPIDEMICS; Subject Term: MEDICAL care; Subject Term: PUBLIC health; Author-Supplied Keyword: health systems; Author-Supplied Keyword: rapid appraisal; Author-Supplied Keyword: systems analysis; Author-Supplied Keyword: toolkit; NAICS/Industry Codes: 525120 Health and Welfare Funds; Number of Pages: 7p; Illustrations: 1 chart, 3 diagrams; Document Type: Article.